Journal
JOURNAL OF HEALTHCARE ENGINEERING
Volume 3, Issue 4, Pages 503-533Publisher
HINDAWI LTD
DOI: 10.1260/2040-2295.3.4.503
Keywords
cancer; diagnostic; protein assay; personalized cancer treatment; molecular diagnostic
Categories
Funding
- NIH [R01GM074691]
- NSF
- NIH [R01GM074691]
- NSF
Ask authors/readers for more resources
Cancer treatment is often hindered by inadequate methods for diagnosing the disease or insufficient predictive capacity regarding therapeutic efficacy. Targeted cancer treatments, including Bcr-Abl and EGFR kinase inhibitors, have increased survival for some cancer patients but are ineffective in other patients. In addition, many patients who initially respond to targeted inhibitor therapy develop resistance during the course of treatment. Molecular analysis of cancer cells has emerged as a means to tailor treatment to particular patients. While DNA analysis can provide important diagnostic information, protein analysis is particularly valuable because proteins are more direct mediators of normal and diseased cellular processes. In this review article, we discuss current and emerging protein assays for improving cancer treatment, including trends toward assay miniaturization and measurement of protein activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available